From the Journals

Breakthrough infections twice as likely to be asymptomatic

Publish date: September 1, 2021

 

FROM THE LANCET INFECTIOUS DISEASES

The authors of the new research paper believe their findings may have implications for health policies regarding the timing between vaccine doses, COVID-19 booster shots, and for continuing personal protective measures.

The authors of the paper and Dr. Hijano disclosed no conflicts.

Pages

Recommended Reading

Delta whiplash: How the new surge is affecting mental health
MDedge Hematology and Oncology
Shouldn’t docs who spread false COVID-19 info lose their licenses?
MDedge Hematology and Oncology
FDA fully approves Pfizer COVID-19 vaccine
MDedge Hematology and Oncology
Plastic barriers may not stop COVID-19 spread, experts say
MDedge Hematology and Oncology
Health care workers eager for COVID booster shots
MDedge Hematology and Oncology
COVID booster may benefit active-treatment cancer patients
MDedge Hematology and Oncology
A hot dog a day takes 36 minutes away
MDedge Hematology and Oncology
Advocates seek to reframe masks as a disability accommodation
MDedge Hematology and Oncology
CDC panel unanimously backs Pfizer vax, fortifying FDA approval
MDedge Hematology and Oncology
COVID-clogged ICUs ‘terrify’ those with chronic or emergency illness
MDedge Hematology and Oncology